Background: Woven EndoBridge (WEB; Sequent Medical) treatment is an innovative endovascular approach for treatment of wide-neck bifurcation aneurysms. Initial studies have shown high safety with good efficacy at short term confirmed by trials conducted in United States (WEB-Intrasaccular Therapy) and in Europe (WEB Clinical Assessment of Intrasaccular Aneurysm Therapy [WEBCAST], French Observatory, and WEBCAST-2).
Objective: To report the 2-yr clinical and anatomical results of WEB treatment in the combined population of 3 European trials.
Methods: In a French Observatory, 2-yr clinical and anatomical data were collected. In WEBCAST and WEBCAST-2, 2-yr follow-up was optional, and data were collected when follow-up was performed. Aneurysm occlusion was evaluated using a 3-grade scale: complete occlusion, neck remnant, and aneurysm remnant.
Results: The population for safety was 138/168 patients (82.1%), including 89 females (64.5%), with mean age of 55.5 ± 10.2 yr. The population for efficacy was 121/169 aneurysms (71.6%). Aneurysm locations were middle cerebral artery in 65/121 aneurysms (53.7%), anterior-communicating artery in 25/121 (20.7%), basilar artery in 17/121 (14.0%), and internal carotid artery terminus in 14/121 (11.6%). No clinically relevant adverse events occurred between years 1 and 2. At 2 yr, complete occlusion was observed in 62/121 (51.2%) aneurysms, neck remnant in 36/121 (29.8%) aneurysms, and aneurysm remnant in 23/121 (19.0%) aneurysms. The global retreatment rate at 2 yr was 9.3%.
Conclusion: This analysis confirms the high safety profile of WEB treatment at 2 yr. Aneurysm occlusion is generally stable at 2 yr, and the retreatment rate between 1 yr and 2 yr is low (2.0%).
Keywords: Aneurysms; Endovascular treatment; Flow disruption; WEB device.
© Congress of Neurological Surgeons 2020.
Safety and efficacy of aneurysm treatment with WEB in the cumulative population of three prospective, multicenter series.J Neurointerv Surg. 2018 Jun;10(6):553-559. doi: 10.1136/neurintsurg-2017-013448. Epub 2017 Sep 30. J Neurointerv Surg. 2018. PMID: 28965106 Free PMC article. Clinical Trial.
Clinical and Anatomical Follow-up in Patients With Aneurysms Treated With the WEB Device: 1-Year Follow-up Report in the Cumulated Population of 2 Prospective, Multicenter Series (WEBCAST and French Observatory).Neurosurgery. 2016 Jan;78(1):133-41. doi: 10.1227/NEU.0000000000001106. Neurosurgery. 2016. PMID: 26552042 Free PMC article. Clinical Trial.
Safety and Efficacy of Aneurysm Treatment with the WEB: Results of the WEBCAST 2 Study.AJNR Am J Neuroradiol. 2017 Jun;38(6):1151-1155. doi: 10.3174/ajnr.A5178. Epub 2017 Apr 27. AJNR Am J Neuroradiol. 2017. PMID: 28450432 Clinical Trial.
Efficacy and Safety of the Woven EndoBridge (WEB) Device for the Treatment of Intracranial Aneurysms: A Systematic Review and Meta-Analysis.AJNR Am J Neuroradiol. 2016 Dec;37(12):2287-2292. doi: 10.3174/ajnr.A4900. Epub 2016 Aug 11. AJNR Am J Neuroradiol. 2016. PMID: 27516237 Review.
The Woven Endobridge Device for Treatment of Intracranial Aneurysms: A Systematic Review.World Neurosurg. 2017 Feb;98:809-817.e1. doi: 10.1016/j.wneu.2016.11.020. Epub 2016 Nov 14. World Neurosurg. 2017. PMID: 27856383 Review.